LU90118B1 - Use of melatonin in the treatment of patients with addiction to certain drugs - Google Patents

Use of melatonin in the treatment of patients with addiction to certain drugs Download PDF

Info

Publication number
LU90118B1
LU90118B1 LU90118A LU90118A LU90118B1 LU 90118 B1 LU90118 B1 LU 90118B1 LU 90118 A LU90118 A LU 90118A LU 90118 A LU90118 A LU 90118A LU 90118 B1 LU90118 B1 LU 90118B1
Authority
LU
Luxembourg
Prior art keywords
melatonin
addiction
patients
treatment
certain drugs
Prior art date
Application number
LU90118A
Other languages
French (fr)
Inventor
Nava Zisapel
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Application granted granted Critical
Publication of LU90118B1 publication Critical patent/LU90118B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
LU90118A 1995-02-01 1997-08-01 Use of melatonin in the treatment of patients with addiction to certain drugs LU90118B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (1)

Publication Number Publication Date
LU90118B1 true LU90118B1 (en) 1997-11-13

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
LU90118A LU90118B1 (en) 1995-02-01 1997-08-01 Use of melatonin in the treatment of patients with addiction to certain drugs

Country Status (22)

Country Link
JP (1) JP4516159B2 (en)
CN (1) CN1083263C (en)
AT (1) AT408188B (en)
AU (1) AU695366B2 (en)
BG (1) BG62876B1 (en)
BR (1) BR9607169A (en)
CZ (1) CZ291349B6 (en)
DK (1) DK176081B1 (en)
EE (1) EE03384B1 (en)
FI (1) FI119586B (en)
IS (1) IS1980B (en)
LU (1) LU90118B1 (en)
LV (1) LV11940B (en)
MD (1) MD1716C2 (en)
NO (1) NO312814B1 (en)
NZ (1) NZ298878A (en)
PL (1) PL183148B1 (en)
SI (1) SI9620022A (en)
SK (1) SK284521B6 (en)
TR (1) TR199700723T1 (en)
TW (1) TW483757B (en)
WO (1) WO1996023496A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0016918A (en) 2000-01-05 2004-03-23 Neurim Pharma 1991 Process and formulation for treating antihypertensive resistance and related conditions
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Composition for treating insomnia
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
JP2015509106A (en) 2012-01-26 2015-03-26 ヴァンダ ファーマシューティカルズ インコーポレイテッ Treatment of circadian rhythm disorders
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
ES2805376T3 (en) 2012-12-18 2021-02-11 Vanda Pharmaceuticals Inc Tasimelteon for treating circadian rhythm disorders
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
EP3337462B1 (en) * 2016-10-31 2020-09-30 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0518468T3 (en) * 1991-05-09 2000-01-31 Neurim Pharma 1991 Melatonin-containing compositions
IT1251544B (en) * 1991-05-13 1995-05-17 Gabriele Biella PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE

Also Published As

Publication number Publication date
FI973185A0 (en) 1997-07-31
TR199700723T1 (en) 1998-02-21
CZ291349B6 (en) 2003-02-12
CN1083263C (en) 2002-04-24
MD1716C2 (en) 2002-02-28
BG62876B1 (en) 2000-10-31
PL183148B1 (en) 2002-05-31
WO1996023496A1 (en) 1996-08-08
DK176081B1 (en) 2006-04-18
TW483757B (en) 2002-04-21
JPH10513177A (en) 1998-12-15
BR9607169A (en) 1997-11-11
LV11940B (en) 1998-05-20
DK89697A (en) 1997-07-30
AU695366B2 (en) 1998-08-13
ATA901396A (en) 2001-02-15
NO973531L (en) 1997-09-30
AU4457496A (en) 1996-08-21
SK284521B6 (en) 2005-05-05
SI9620022A (en) 1998-10-31
CZ240597A3 (en) 1998-01-14
AT408188B (en) 2001-09-25
FI119586B (en) 2009-01-15
SK103097A3 (en) 1998-01-14
MD970254A (en) 1999-05-31
IS1980B (en) 2005-01-14
CN1172431A (en) 1998-02-04
FI973185A (en) 1997-09-30
PL321630A1 (en) 1997-12-08
BG101803A (en) 1998-04-30
MX9705856A (en) 1998-07-31
EE03384B1 (en) 2001-04-16
NO973531D0 (en) 1997-07-31
JP4516159B2 (en) 2010-08-04
NZ298878A (en) 1999-05-28
LV11940A (en) 1998-01-20
EE9700166A (en) 1998-02-16
IS4532A (en) 1997-07-25
NO312814B1 (en) 2002-07-08
MD1716B2 (en) 2001-08-31

Similar Documents

Publication Publication Date Title
CY2007001I1 (en) MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
IT9083334A0 (en) PROCEDURE FOR THE EXTRACTION AND PURIFICATION OF HUMAN GENOMIC DNA
DE69332952D1 (en) Biocompatible polymers containing diagnostic and therapeutic units
FI94028B (en) Device for the diagnosis and treatment of nasal diseases
DE69635364D1 (en) Blood filter and extracorporeal circulation
HUP0104803A3 (en) Process and system for the administration of medicine through the skin
LU90118B1 (en) Use of melatonin in the treatment of patients with addiction to certain drugs
HK1001375A1 (en) Use of acetylsalicylic acid in the manufacture of a drug for the treatment of skin injuries
FR2717080B1 (en) Use of eipriprodil and its enantiomers for the preparation of medicaments useful in the treatment of peripheral neuropathies and central neurodegenerative diseases.
FI941345A0 (en) Retinoids and their use in the treatment of skin diseases and leukemia
KR960702315A (en) Therapeutic Use of Hemoglobin in the Treatment of Blood Vessel Blockage
FR2684552B1 (en) USE OF D-FENFLURAMINE AND FENFLURAMINE DERIVATIVES IN THE TREATMENT OF HYPERTENSION IN INSULIN RESISTANT SUBJECTS.
FR2792199B3 (en) USE OF OSANETANT FOR THE PREPARATION OF MEDICINES USEFUL IN THE TREATMENT OF MOOD DISORDERS
FR2759906B1 (en) USE OF MILNACIPRAN AND DERIVATIVES THEREOF FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF CERTAIN PSYCHIATRIC DISEASES
FR2774596B1 (en) USE OF SELENATED COMPOUNDS IN THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE
ZA9610584B (en) Use of rc-9 in diagnosis and treatment of proliferative arterial disease
FR2722989B1 (en) USE OF IFENPRODIL AND ITS ENANTIOMERS FOR THE PREPARATION OF MEDICINES USEFUL IN THE TREATMENT OF PERIPHERAL NEUROPATHIES AND CENTRAL NEURODEGENERATIVE DISEASES
GB2284153B (en) Substances for use in treatment of HIV-infection in HIV-infected patients
GB9401745D0 (en) Improvements in and relating to the administration of medicaments or therapeutic substances
FR2702151B1 (en) Application of anti-convulsants in the treatment of neuro-AIDS.
GB9701919D0 (en) Materials and methods relating to the diagnosis of susceptibility to HIV-1 infection and to treatment methods related to HIV-1
FR2758980B1 (en) LOCAL AND GENERAL BODY TREATMENT HYDROTHERAPY APPARATUS
FR2744363B1 (en) APPLICATION OF THIAZOLIDINE DERIVATIVES TO THE PREPARATION OF DRUGS FOR THE TREATMENT OF DRUG ABUSE OR SUBSTANCES GIVEN TO PHARMACOMANIA OR EXCESSIVE USE
ID28817A (en) USE OF TETRAHIDROPIRIDIN (OR 4-HIDROPIPERIDIN) -BUTILAZOL DRUGS IN THE MAKING OF DRUGS FOR PAIN TREATMENT
FR2727864B1 (en) USE OF LIGANDS FROM THE PERIPHERAL BINDING SITES FOR BENZODIAZEPINES FOR THE PREPARATION OF DRUGS USEFUL IN THE TREATMENT OF PERIPHERAL NEUROPATHIES